Clinical impact of [18F] Fluorodeoxyglucose positron emission tomography/computed tomography on management of patients with muscle-invasive bladder cancer

Clinical impact of [18F] Fluorodeoxyglucose positron emission tomography/computed tomography on management of patients with muscle-invasive bladder cancer

Bibliographic Details
Main Authors:	C.S. Voskuilen, E.J. Van Gennep, E. Vegt, M. Donswijk, E.E. Fransen Van De Putte, H.G. Van Der Poel, S. Horenblas, B.W.G. Van Rhijn, K. Hendricksen, L.S Mertens
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320331384

Similar Items

Role of fluorodeoxyglucose positron emission tomography-Computed tomography in thyroid malignancy
by: Ajay Manickam, et al.
Published: (2017-01-01)

Fluorodeoxyglucose positron emission tomography findings in NMDA receptor antibody encephalitis
by: P E J Caballero
Published: (2011-01-01)

Role of Positron Emission Tomography with Fluorodeoxyglucose in Prostate Cancer
by: Yiyan Liu
Published: (2013-09-01)

Hepatic Pseudolymphoma with Fluorodeoxyglucose Uptake on Positron Emission Tomography
by: Kazuhiro Suzumura, et al.
Published: (2017-12-01)

The 18F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer
by: Mihailović Jasna, et al.
Published: (2017-01-01)

Clinical utility of 18fluorodeoxyglucose positron emission tomography-computed tomography in rheumatology
by: Sirisha Kommireddy, et al.
Published: (2021-01-01)

Candida pyelonephritis on 18F-fluorodeoxyglucose positron emission tomography/computed tomography
by: Junwei Zhang, et al.
Published: (2016-10-01)

In vitro imaging of bacteria using 18F-fluorodeoxyglucose micro positron emission tomography
by: Marjolein Heuker, et al.
Published: (2017-07-01)

Neurolymphomatosis detected by 18F‐fluorodeoxyglucose‐positron emission tomography
by: Yoshikazu Hori, et al.
Published: (2020-07-01)

Detection of Pacemaker Lead Infection by Fluorodeoxyglucose Positron Emission Tomography
by: Takashi Miura, MD, et al.
Published: (2006-01-01)

Assessment of Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Carcinoma of Unknown Primary
by: S. A. Yaremenko, et al.
Published: (2021-09-01)

18F-fluorodeoxyglucose positron emission tomography / computed tomography in primary Ewing sarcoma of the lung
by: Zivgarević Ljiljana, et al.
Published: (2022-01-01)

18-Fluorodeoxyglucose positron emission tomography/computed tomography for large vessel vasculitis in clinical practice
by: Kladoum Nassarmadji, et al.
Published: (2023-01-01)

The Role of Preoperative 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Retroperitoneal Sarcoma
by: Sung Jun Jo, et al.
Published: (2022-05-01)

18F-fluorodeoxyglucose positron emission tomography/computed tomography of bilateral primary ureter lymphoma
by: Liang Yin, et al.
Published: (2021-05-01)

Diagnostic errors of coronavirus infection: Role of fluorodeoxyglucose positron emission tomography/computed tomography scan
by: Abtin Doroudinia, et al.
Published: (2020-01-01)

18F-fluorodeoxyglucose positron emission tomography in elderly patients with an elevated erythrocyte sedimentation rate of unknown origin.
by: Karel-Jan D F Lensen, et al.
Published: (2013-01-01)

Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose
by: Jing Zhu, et al.
Published: (2022-10-01)

Comparison of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Hydro-Stomach Computed Tomography, and Their Combination for Detecting Primary Gastric Cancer
by: Hye Young Jang, et al.
Published: (2015-01-01)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
by: Gillies, R, et al.
Published: (2011)

18F fluorodeoxyglucose positron-emission tomography–computed tomography in the diagnosis of brachial plexopathy in carcinoma breast
by: Suma Tammineni Medara, et al.
Published: (2022-01-01)

Multiple lytic lesions on F-18 fluorodeoxyglucose positron emission tomography/computed tomography not always metastatic?
by: Averilicia Passah, et al.
Published: (2018-01-01)

The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma
by: Athanasios Bantis, et al.
Published: (2016-01-01)

Diagnostic utility of positron emission tomography-computed tomography and indications for 18F-Fluorodeoxyglucose and amyloid-tracers
by: Maria Lucia Calcagni, et al.
Published: (2018-11-01)

Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer
by: Takuya Adachi, et al.
Published: (2020-07-01)

The role of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in the differential diagnosis of pericardial disease
by: Cheol Won Hyeon, et al.
Published: (2020-12-01)

Quantitative 18F-fluorodeoxyglucose positron emission tomography/computed tomography to assess pulmonary inflammation in COPD
by: Laurence Vass, et al.
Published: (2021-08-01)

Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating lung cancer recurrence
by: Nobuhiro Asai, et al.
Published: (2013-04-01)

Metastatic cervical paravertebral solitary fibrous tumor detected by fluorodeoxyglucose positron emission tomography-computed tomography
by: Hoiwan Cheung, MD, et al.
Published: (2018-04-01)

18F-Fluorodeoxyglucose positron emission tomography may not visualize radiation pneumonitis
by: Meiying Guo, et al.
Published: (2019-12-01)

Fluorodeoxyglucose Positron Emission Tomography integrated with computed tomography in carcinoma of the cervix: Its impact on accurate staging and the predictive role of its metabolic parameters.
by: Ismaheel O Lawal, et al.
Published: (2019-01-01)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
by: Gillies, R, et al.
Published: (2010)

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
by: Mohammed Al‐Zubaidi, et al.
Published: (2024-04-01)

ROLE OF COMBINED 18-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN THE MANAGEMENT OF PATIENTS WITH DIFFERENTIATED THYROID CANCER
by: T. M. Geliashvili, et al.
Published: (2017-05-01)

[18F]fluorodeoxyglucose positron emission tomography/computed tomography characteristics of primary mediastinal germ cell tumors
by: Koeun Lee, et al.
Published: (2023-10-01)

Relationship between Prognostic Stage in Breast Cancer and Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Mio Mori, et al.
Published: (2021-07-01)

A case report of calcific aterosclerosis demonstrated on 18-F-fluorodeoxyglucose positron emission tomography/computed tomography
by: Antonella Laria, et al.
Published: (2021-10-01)

Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
by: Susanna Nuvoli, et al.
Published: (2018-02-01)

Fluorodeoxyglucose-positron emission tomography/computed tomography-based chemotherapy dosage adjustment in seminoma: The GETUG SEMITEP trial
by: Dheeraj Kumar Dheeroo
Published: (2022-01-01)

Prognostic value of metabolic parameters on 18F-fluorodeoxyglucose positron tomography/computed tomography in classical rectal adenocarcinoma
by: Byung Wook Choi, et al.
Published: (2021-06-01)